THE BENEFIT OF COLONOSCOPY

被引:43
作者
BRENNA, E
SKREDEN, K
WALDUM, HL
MARVIK, R
DYBDAHL, JH
KLEVELAND, PM
SANDVIK, AK
HALVORSEN, T
MYRVOLD, HE
PETERSEN, H
机构
[1] TRONDHEIM REG & UNIV HOSP,DEPT SURG,TRONDHEIM,NORWAY
[2] TRONDHEIM REG & UNIV HOSP,DEPT PATHOL,TRONDHEIM,NORWAY
关键词
Colonoscopy; Colorectal carcinoma; Colorectal polyps; Inflammatory bowel disease;
D O I
10.3109/00365529008999213
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In a prospective study involving 833 consecutive outpatient and open-access colono-scopies, attempts were made to characterize the benefit of colonoscopy in terms of both predicted and unpredicted findings and therapeutic procedures. The endoscopist therefore predicted the endoscopic findings before the endoscopy. The results were compared for the different indications for colonoscopy. The overall agreement between the predictions and the colonoscopic findings was 61% Clinically significant abnormalities were found in about half the examinations. The most frequent abnormal findings were benign polyps (24% inflammatory bowel disease (17% and malignancy (5% In about half the patients with a malignancy the indication for colonoscopy was rectal bleeding, and half of the malignancies were not predicted. The greatest benefit of colonoscopy was found in patients referred because of overt rectal bleeding or occult faecal blood, and abnormal barium enema or endoscopy findings. The importance of complete colonoscopy in connection with operation for colorectal carcinoma is emphasized. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 34 条
[1]  
ALDRIDGE MC, 1986, LANCET, V2, P833
[2]  
BOULOS PB, 1984, LANCET, V1, P95
[3]  
CARLSSON G, 1987, ARCH SURG-CHICAGO, V122, P1261
[4]  
DURDEY P, 1987, LANCET, V2, P549
[5]   THE CLINICAL BENEFIT OF ROUTINE UPPER GASTROINTESTINAL ENDOSCOPY [J].
FJOSNE, U ;
KLEVELAND, PM ;
WALDUM, H ;
HALVORSEN, T ;
PETERSEN, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 (04) :433-440
[6]  
GILBERTS.VA, 1974, CANCER, V34, P936, DOI 10.1002/1097-0142(197409)34:3+<936::AID-CNCR2820340722>3.0.CO
[7]  
2-5
[8]  
GILBERTSEN VA, 1978, CANCER, V41, P1137, DOI 10.1002/1097-0142(197803)41:3<1137::AID-CNCR2820410350>3.0.CO
[9]  
2-G
[10]  
GOULSTON KJ, 1986, LANCET, V2, P261